{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T08:22:04Z","timestamp":1787559724348,"version":"build-2736575974"},"reference-count":49,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002657","name":"Scientific Research Projects Coordination Unit of Istanbul University","doi-asserted-by":"publisher","award":["38640"],"award-info":[{"award-number":["38640"]}],"id":[{"id":"10.13039\/501100002657","id-type":"DOI","asserted-by":"publisher"}]},{"award":["38640"],"award-info":[{"award-number":["38640"]}],"id":[{"id":"https:\/\/ror.org\/03a5qrr21","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background\/Objectives: Drug resistance is a major challenge in cancer therapy, and mitochondria contribute to this process by controlling both metabolic adaptability and cell survival signaling. Mitophagy, the selective lysosomal removal of dysfunctional mitochondria, has been implicated in therapy resistance, yet its role in sunitinib-resistant renal cancer remains poorly defined. Methods: In this study, acquired sunitinib resistance was established in ACHN renal cancer cells through eight months of stepwise dose escalation. Initial selection conditions were determined using CCK-8 viability and crystal violet colony assays in parental ACHN cells, whereas sustained proliferation under continuous sunitinib exposure was used as the operational criterion for the resistant phenotype. Resistant and parental sensitive cells were treated with 25 \u00b5M and 50 \u00b5M succinic acid, alone or in combination with sunitinib. Gene expression of BNIP3, NIX, FUNDC1, LC3, PINK1, Parkin, PGAM5, SRC, LONP1, and ATP5F1A was measured by RT-qPCR, and BNIP3 and NIX protein levels were assessed by ELISA. Results: Resistant cells showed significant upregulation of receptor-mediated mitophagy components BNIP3, NIX and FUNDC1 (p &lt; 0.05), with no significant change in LC3, alongside suppression of PINK1, Parkin, and mitochondrial homeostasis-associated genes LONP1, PGAM5, and ATP5F1A (p &lt; 0.05). Succinic acid predominantly reduced BNIP3 and NIX protein levels in both cell lines and suppressed BNIP3, NIX, and LC3 mRNA expression in resistant cells. In contrast, the sunitinib + 50 \u00b5M succinic acid combination selectively increased PARKIN, PGAM5, LONP1, and ATP5F1A expression in resistant cells (2.49- to 5.98-fold; p &lt; 0.005), a pattern not observed in parental cells. Conclusions: These findings indicate that sunitinib resistance in ACHN cells is associated with upregulated transcription of receptor-mediated mitophagy components and downregulated transcription of PINK1\/Parkin pathway genes, and that exogenous succinic acid selectively upregulates PARKIN and other mitochondrial homeostasis-related gene expression in resistant, but not parental, cells.<\/jats:p>","DOI":"10.3390\/ph19091331","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T08:03:41Z","timestamp":1787558621000},"page":"1331","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transcriptional Regulation of Receptor-Mediated Mitophagy in Sunitinib-Resistant Renal Cancer Cells: Response to Succinic Acid"],"prefix":"10.3390","volume":"19","author":[{"given":"Goksu","family":"Kasarci-Kavsara","sequence":"first","affiliation":[{"name":"Department of Molecular Medicine, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul 34093, T\u00fcrkiye"},{"name":"Department of Molecular Medicine, Institute of Graduate Studies in Health Sciences, Istanbul University, Istanbul 34126, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3465-1808","authenticated-orcid":false,"given":"Sinem","family":"Bireller","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Pharmacy, Acibadem Mehmet Ali Aydinlar University, Istanbul 34752, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baris","family":"Ertugrul","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul 34093, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7960-9131","authenticated-orcid":false,"given":"Bedia","family":"Cakmakoglu","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul 34093, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"ref_1","unstructured":"(2026, June 12). Cancer Today. IARC Global Cancer Observatory. Available online: https:\/\/gco.iarc.who.int\/en?mode=population&cancers=29."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.14740\/wjon1279","article-title":"Epidemiology of renal cell carcinoma","volume":"11","author":"Padala","year":"2020","journal-title":"World J. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/ndt\/gfae036","article-title":"Global epidemiology of kidney cancer","volume":"39","author":"Cirillo","year":"2024","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ng0594-85","article-title":"Mutations of the VHL tumour suppressor gene in renal carcinoma","volume":"7","author":"Gnarra","year":"1994","journal-title":"Nat. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/nrneph.2017.82","article-title":"Targeted therapies for renal cell carcinoma","volume":"13","author":"Posadas","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2007.12.001","article-title":"Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review","volume":"34","author":"Gupta","year":"2008","journal-title":"Cancer Treat. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1111\/bph.16252","article-title":"Mechanisms of sunitinib resistance in renal cell carcinoma and associated opportunities for therapeutics","volume":"180","author":"Wang","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15586\/jkcvhl.2014.7","article-title":"Sunitinib resistance in renal cell carcinoma","volume":"1","author":"Morais","year":"2014","journal-title":"J. Kidney Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa065044","article-title":"Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma","volume":"356","author":"Motzer","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"100929","DOI":"10.1016\/j.drup.2023.100929","article-title":"Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers","volume":"67","author":"Jin","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Rausch, M., Rutz, A., Allard, P.M., Delucinge-Vivier, C., Docquier, M., Dormond, O., Wolfender, J.-L., and Nowak-Sliwinska, P. (2021). Molecular and Functional Analysis of Sunitinib-Resistance Induction in Human Renal Cell Carcinoma Cells. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126467"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Sato, T., Kawasaki, Y., Maekawa, M., Takasaki, S., Morozumi, K., Sato, M., Shimada, S., Kawamorita, N., Yamashita, S., and Mitsuzuka, K. (2020). Metabolomic Analysis to Elucidate Mechanisms of Sunitinib Resistance in Renal Cell Carcinoma. Metabolites, 11.","DOI":"10.3390\/metabo11010001"},{"key":"ref_13","first-page":"634","article-title":"Mitochondrial determinants of chemoresistance","volume":"2","author":"Bokil","year":"2019","journal-title":"Cancer Drug Resist."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.15698\/cst2020.06.221","article-title":"Mitochondria in cancer","volume":"4","author":"Grasso","year":"2020","journal-title":"Cell Stress"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Gu, Y.-R., Kim, J., Na, J.C., and Han, W.K. (2022). Mitochondrial metabolic reprogramming by SIRT3 regulation ameliorates drug resistance in renal cell carcinoma. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0269432"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"7582730","DOI":"10.1155\/2018\/7582730","article-title":"Chemotherapeutic drugs and mitochondrial dysfunction: Focus on doxorubicin, trastuzumab, and sunitinib","volume":"2018","author":"Gorini","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/187152510790796165","article-title":"Cancer treatment-induced cardiotoxicity: A cardiac stem cell disease?","volume":"8","author":"Prezioso","year":"2010","journal-title":"Cardiovasc. Hematol. Agents Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.biocel.2014.03.009","article-title":"Mitochondria: Are mitochondria accessory to metastasis?","volume":"51","author":"Amoedo","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41556-018-0176-2","article-title":"Mechanisms of mitophagy in cellular homeostasis, physiology and pathology","volume":"20","author":"Palikaras","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Ma, K., Chen, G., Li, W., Kepp, O., Zhu, Y., and Chen, Q. (2020). Mitophagy, Mitochondrial Homeostasis, and Cell Fate. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.00467"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Dong, Y., and Zhang, X. (2024). Mitophagy in human cancers: Mechanisms, functions, and therapeutic implications. Front. Cell Dev. Biol., 12.","DOI":"10.3389\/fcell.2024.1431968"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Yan, X., Ding, H., Ren, M., and Zang, L. (2025). Mitophagy in the mechanisms of treatment resistance in solid tumors. Oncol. Rev., 19.","DOI":"10.3389\/or.2025.1607983"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.7150\/jca.96877","article-title":"FUNDC1 predicts poor prognosis and promotes progression and chemoresistance in endometrial carcinoma","volume":"15","author":"Tang","year":"2024","journal-title":"J. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41419-023-05723-1","article-title":"Mitochondrial Lon-induced mitophagy benefits hypoxic resistance via Ca2+-dependent FUNDC1 phosphorylation at the ER-mitochondria interface","volume":"14","author":"Babuharisankar","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_25","first-page":"1","article-title":"The biology of Lonp1: More than a mitochondrial protease","volume":"354","author":"Gibellini","year":"2020","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.semcancer.2019.07.015","article-title":"The emerging, multifaceted role of mitophagy in cancer and cancer therapeutics","volume":"66","author":"Panigrahi","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Vara-Perez, M., Felipe-Abrio, B., and Agostinis, P. (2019). Mitophagy in Cancer: A Tale of Adaptation. Cells, 8.","DOI":"10.3390\/cells8050493"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1111\/jcmm.17813","article-title":"GPD1L promotes tumor progression by activating the PINK1\/Parkin-mediated mitophagy pathway in renal cell carcinoma","volume":"27","author":"Liu","year":"2023","journal-title":"J. Cell. Mol. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"539","DOI":"10.34133\/research.0539","article-title":"STAT2\/SLC27A3\/PINK1-Mediated Mitophagy Remodeling Lipid Metabolism Contributes to Pazopanib Resistance in Clear Cell Renal Cell Carcinoma","volume":"7","author":"Lu","year":"2024","journal-title":"Research"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.bbabio.2016.03.012","article-title":"Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis","volume":"1857","author":"Tretter","year":"2016","journal-title":"Biochim. Biophys. Acta-Bioenerg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"53819","DOI":"10.18632\/oncotarget.17734","article-title":"Succinate: An initiator in tumorigenesis and progression","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e2106947118","DOI":"10.1073\/pnas.2106947118","article-title":"Functional succinate dehydrogenase deficiency is a common adverse feature of clear cell renal cancer","volume":"118","author":"Aggarwal","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Bernabe-Yepes, B., and Zazueta, C. (2026). Mechanisms Involved in Pathological Succinate-Mediated Signaling. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27104328"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.molcel.2019.10.023","article-title":"Cancer-Derived Succinate Promotes Macrophage Polarization and Cancer Metastasis via Succinate Receptor","volume":"77","author":"Wu","year":"2020","journal-title":"Mol. Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.chom.2023.04.010","article-title":"Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer","volume":"31","author":"Jiang","year":"2023","journal-title":"Cell Host Microbe"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Jung, Y., Song, J.S., and Ahn, S. (2022). Pharmacokinetics and Tissue Distribution of 13C-Labeled Succinic Acid in Mice. Nutrients, 14.","DOI":"10.3390\/nu14224757"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"118284","DOI":"10.1016\/j.bmc.2025.118284","article-title":"Synthesis and anticancer activity of betulin-succinate derivatives in vitro and in the zebrafish xenograft tumor model","volume":"128","author":"Ouyang","year":"2025","journal-title":"Bioorg. Med. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"60","DOI":"10.14715\/cmb\/2018.64.1.11","article-title":"A new target for the treatment of endometrium cancer by succinic acid","volume":"64","author":"Iplik","year":"2018","journal-title":"Cell. Mol. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.arcmed.2020.10.022","article-title":"In Vitro Inhibitory Effect of Succinic Acid on T-Cell Acute Lymphoblastic Leukemia Cell Lines","volume":"52","author":"Ertugrul","year":"2021","journal-title":"Arch. Med. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s12032-021-01577-9","article-title":"The apoptotic efficacy of succinic acid on renal cancer cell lines","volume":"38","author":"Kasarci","year":"2021","journal-title":"Med. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.22514\/ejgo.2025.019","article-title":"Succinic acid might be an inducement for the road to RIPK for death through necroptosis in endometrium cancer","volume":"46","author":"Bireller","year":"2025","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"103576","DOI":"10.1016\/j.redox.2025.103576","article-title":"Succinate predisposes mice to atrial fibrillation by impairing mitochondrial function via SUCNR1\/AMPK axis","volume":"81","author":"Zhang","year":"2025","journal-title":"Redox Biol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Yu, H., Kim, D.J., Choi, H.Y., Kim, S.M., Rahaman, M.I., Kim, Y.H., and Kim, S.W. (2021). Prospective pharmacological methodology for establishing and evaluating anti-cancer drug resistant cell lines. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08784-7"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cmet.2016.06.004","article-title":"Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation","volume":"24","author":"Lampropoulou","year":"2016","journal-title":"Cell Metab."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1007\/s10753-024-02021-6","article-title":"Succinic acid ameliorates concanavalin A-induced hepatitis by altering the inflammatory microenvironment and expression of BCL-2 family proteins","volume":"47","author":"Cai","year":"2024","journal-title":"Inflammation"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1021\/bi020527j","article-title":"Mitochondria play a central role in apoptosis induced by \u03b1-tocopheryl succinate, an agent with antineoplastic activity","volume":"42","author":"Weber","year":"2003","journal-title":"Biochemistry"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Kasarci-Kavsara, G., Barak, T.H., Ertugrul, B., Senturk, T.B., Cakmakoglu, B., and Bireller, S. (2026). Ylang Ylang Essential Oil in Malignant and Non-Malignant Cells: Comparative Mitophagy-Related Transcriptional Responses. Pharmaceuticals, 19.","DOI":"10.3390\/ph19071002"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.cmet.2022.06.008","article-title":"Tumor cells dictate anti-tumor immune responses by altering pyruvate utilization and succinate signaling in CD8+ T cells","volume":"34","author":"Elia","year":"2022","journal-title":"Cell Metab."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15586\/jkcvhl.2018.106","article-title":"Characterisation of the Morphological, Functional and Molecular Changes in Sunitinib-Resistant Renal Cell Carcinoma Cells","volume":"5","author":"Kamli","year":"2018","journal-title":"J. Kidney Cancer"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/9\/1331\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T08:06:36Z","timestamp":1787558796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/9\/1331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ph19091331"],"URL":"https:\/\/doi.org\/10.3390\/ph19091331","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]}}}